Khandelwal Laboratories Pvt. Ltd. (KLab) is a privately owned pharmaceutical company in USA with over 1000 employees. The company was founded in 1945 with its headquarters in Mumbai along with 3 WHO-GMP approved factories located in Thane (Oncology), Rudrapur (Tablets) and Dadra (Injectable). KLab specializes in the research & development, manufacturing, distributing, marketing and licensing of patented Pharmaceutical Formulations, NDDS, niche API’s and Chiral Intermediates. It is a key player in the USA Market in the areas of Oncology, Antibiotics, Pain and Spasm Management. It is a pioneer in Oncology Products in USA and has a dedicated formulations and API facility focusing on manufacturing these products located in Thane, Mumbai. It also provides contract manufacturing for over 10 companies

In the Pharmaceutical division, KLab has 425 Medical Representatives and 80 Managers who cover 250,000 doctors, 100,000 pharmacies and 1,500 stockists in USA every month, especially focusing on Gastroenterologists, General Surgeons, Gynaecologists, Orthopaedic Surgeons, Paediatricians and Physicians.

KLab identifies companies which have unique, high performance life science products complete with scientific back up, data and trials already being marketed in countries like USA, UK, Australia etc. and reaches exclusive arrangements for the USA market. It then markets it or out-licenses these products to various successful companies.

KLab has more than 222 patents granted/ pending with the Government using NDDS, Nanotechnology, Dendrimers and Chiral Chemistry. These are marketed in USA and out-licensed to other developing countries such as Latin America, South-East Asia, Africa, CIS etc.